These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24785215)

  • 1. Genotype-guided dosing of vitamin K antagonists.
    Schwarz UI; Kim RB; Tirona RG
    N Engl J Med; 2014 May; 370(18):1761-2. PubMed ID: 24785215
    [No Abstract]   [Full Text] [Related]  

  • 2. Genotype-guided dosing of vitamin K antagonists.
    Pereira NL; Rihal CS; Weinshilboum RM
    N Engl J Med; 2014 May; 370(18):1762. PubMed ID: 24785216
    [No Abstract]   [Full Text] [Related]  

  • 3. Genotype-guided dosing of vitamin K antagonists.
    Cavallari LH; Kittles RA; Perera MA
    N Engl J Med; 2014 May; 370(18):1763. PubMed ID: 24785218
    [No Abstract]   [Full Text] [Related]  

  • 4. Genotype-guided dosing of vitamin K antagonists.
    Koller EA; Roche JC; Rollins JA
    N Engl J Med; 2014 May; 370(18):1761. PubMed ID: 24785214
    [No Abstract]   [Full Text] [Related]  

  • 5. Genotype-guided dosing of vitamin K antagonists.
    Kimmel SE; French B; Geller NL;
    N Engl J Med; 2014 May; 370(18):1763-4. PubMed ID: 24785213
    [No Abstract]   [Full Text] [Related]  

  • 6. Genotype-guided dosing of vitamin K antagonists.
    Daneshjou R; Klein TE; Altman RB
    N Engl J Med; 2014 May; 370(18):1762-3. PubMed ID: 24785217
    [No Abstract]   [Full Text] [Related]  

  • 7. Genotype-guided dosing of vitamin K antagonists.
    Pirmohamed M; Wadelius M; Kamali F;
    N Engl J Med; 2014 May; 370(18):1764-5. PubMed ID: 24804303
    [No Abstract]   [Full Text] [Related]  

  • 8. Genotype-guided dosing of vitamin K antagonists.
    Maitland-van der Zee AH; de Boer A; Manolopoulos VG;
    N Engl J Med; 2014 May; 370(18):1765-6. PubMed ID: 24804306
    [No Abstract]   [Full Text] [Related]  

  • 9. Do pharmacogenetics have a role in the dosing of vitamin K antagonists?
    Furie B
    N Engl J Med; 2013 Dec; 369(24):2345-6. PubMed ID: 24251364
    [No Abstract]   [Full Text] [Related]  

  • 10. Warfarin dosing by genotype did not improve time in therapeutic range.
    Dunn A
    Ann Intern Med; 2014 Mar; 160(6):JC8. PubMed ID: 24638186
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacogenetics and coumarin dosing--recalibrating expectations.
    Zineh I; Pacanowski M; Woodcock J
    N Engl J Med; 2013 Dec; 369(24):2273-5. PubMed ID: 24328463
    [No Abstract]   [Full Text] [Related]  

  • 12. Why admixture matters in genetically-guided therapy: missed targets in the COAG and EU-PACT trials.
    Duconge J; Cadilla CL; Seip RL; Ruaño G
    P R Health Sci J; 2015 Sep; 34(3):175-7. PubMed ID: 26454897
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulation therapy: genotype-guided anticoagulation therapy-the jury is still out.
    Roberts A
    Nat Rev Cardiol; 2014 Jan; 11(1):1. PubMed ID: 24302217
    [No Abstract]   [Full Text] [Related]  

  • 14. Using pharmacogenetics in real time to guide therapy: the warfarin example.
    Aminkeng F
    Clin Genet; 2014 Jun; 85(6):533-4. PubMed ID: 24628520
    [No Abstract]   [Full Text] [Related]  

  • 15. Warfarin pharmacogenetics: to genotype or not to genotype, that is the question.
    Cavallari LH; Nutescu EA
    Clin Pharmacol Ther; 2014 Jul; 96(1):22-4. PubMed ID: 24942399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetic-based dosing of warfarin.
    Med Lett Drugs Ther; 2008 May; 50(1286):39-40. PubMed ID: 18487958
    [No Abstract]   [Full Text] [Related]  

  • 17. Genotype-guided dosing of warfarin.
    Mega JL; Giugliano RP
    Clin Chem; 2014 Jul; 60(7):920-2. PubMed ID: 24691686
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic testing for warfarin dosing? Not yet ready for prime time.
    Bussey HI; Wittkowsky AK; Hylek EM; Walker MB
    Pharmacotherapy; 2008 Feb; 28(2):141-3. PubMed ID: 18225960
    [No Abstract]   [Full Text] [Related]  

  • 19. Genes affecting warfarin response-interactive or additive?
    Cavallari LH; Duarte JD
    J Clin Pharmacol; 2015 Mar; 55(3):258-60. PubMed ID: 25385663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of the -1639G > A polymorphism of the VKORC1 gene on the dose of oral anticoagulants acenocoumarol, and warfarin in Chilean patients: alternative models of inheritance].
    López-Hernández D
    Rev Med Chil; 2016 Apr; 144(4):539-41. PubMed ID: 27401392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.